Sionna Therapeutics Inc (SION): Company Short-Term Debts

Official company branding of sionnatx.com (SION)

Sionna Therapeutics Inc (SION) is a biotech startup whose finances remain volatile due to high gene therapy development costs, with the current figure standing at 0.00. While the company develops cystic fibrosis treatments in US laboratories, production is fully outsourced to third-party contractors. The market capitalization trend confirms the potential of Sionna Therapeutics Inc (SION), which aims for segment leadership through unique scientific solutions.

SION Sionna Therapeutics Short-Term Debt (02/08/2025 - 11/01/2026)

Financial and market metric breakdowns for Sionna Corp (SION)

- current quotes and average value forecast:
Price Chart Sionna Therapeutics|SION - Analyst Median Target
- stock exchange capitalization data:
Market Capitalization Sionna Therapeutics Inc|SION - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Sionna Therapeutics|SION - Total Stockholders' Equity|Market Value to Book Value Ratio sionnatx.com|SION - Total Business Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Sionna Therapeutics Inc|SION - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Sionna Therapeutics Inc|SION - Company Aggregate Debts|Debt to Book Value Sionna Therapeutics Inc|SION - Company Long-Term Loans and Borrowings|Company Current Liabilities Sionna Therapeutics|Quick Ratio sionnatx.com
- earnings and multiples data:
SION - Final Profit
Analysis of all company metrics:Sionna Therapeutics - SION
Mass-produced product of Sionna Corp

Sionna Therapeutics Inc (SION) focuses on capital-intensive development of innovative drugs. Current debt on loans and borrowings demonstrates the volume of obligations with a maturity of up to one year. This metric measures liquidity, determining the business's ability to service short-term loans without the risk of default. A low debt level combined with management's authority confirms financial stability. This ensures capital preservation for long-term investing.

Competing companies

TEM - Company Short-Term Debt|Short-Term Debt Volume Qiagen NV QGEN|IONS: Company Short-Term Debts|RGEN - Short-Term Debt Volume|Company Short-Term Debt Avidity Biosciences|Short-Term Debt crisprtx.com CRSP|Company Short-Term Debt GeneDx (WGS)|Ultragenyx Pharmaceutical Inc. - Company Short-Term Indebtedness|Company Short-Term Debt Beam Therapeutics Corp BEAM|SRPT: Company Short-Term Indebtedness|Twist Bioscience - Company Short-Term Debts|TXG - Company Short-Term Debts|NTLA (Intellia Therapeutics, Inc.) - Company Current Liabilities|Stoke Therapeutics Inc - Company Short-Term Loans and Borrowings|Company Current Liabilities BLFS|WVE (Wave Pharma) - Amount of Current Liabilities|Company Short-Term Debts MAZE|PRME (primemedicine.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TSHA (Taysha Gene Therapies, Inc.)|uniQure NV (QURE) - Short-Term Debt|MGTX - Company Short-Term Debt|Company Short-Term Loans and Borrowings RGNX (REGENXBIO Corp)|SLDB: Company Short-Term Debts|ocugen.com (OCGN) - Company Short-Term Debts|Company Short-Term Debt PacBio|Benitec Biopharma Inc - Current Liabilities|Company Short-Term Debts DSGN|RCKT - Short-Term Debt|4D Molecular Therapeutics - Company Current Liabilities|Company Short-Term Debts Lexeo Therapeutics Inc. LXEO|KRRO: Company Current Liabilities|Editas Medicine Inc - Amount of Current Liabilities|SLN: Company Short-Term Debts|PRQR - Short-Term Debt Volume|CDXS (Codexis Inc) - Company Short-Term Debts|Company Current Liabilities sangamo.com (SGMO)|Company Short-Term Debt Nautilus Biotechnology (NAUT)|Short-Term Debt Volume Metagenomi Inc.|Precision BioSciences - Company Current Liabilities|Company Short-Term Loans and Borrowings GBIO|Boundless Bio, Inc. - Company Short-Term Debts|Short-Term Debt Volume Exicure, Inc. XCUR|imunon.com (IMNN) - Company Short-Term Debt|Company Short-Term Indebtedness PHIO|MBIO (Mustang Bio Inc) - Company Short-Term Debts|Company Current Liabilities TransCode (RNAZ)|Company Short-Term Debt Bionano Genomics, Inc. (BNGO)|Short-Term Debt Volume adnas.com|Company Short-Term Debts BLUE (bluebird bio)|Short-Term Debt Volume ImmunoPrecise Antibodies Ltd (IPA)|OMGA - Company Short-Term Debt|Short-Term Debt Singular Genomics Corp|Regulus Therapeutics (RGLS) - Company Short-Term Debt|Company Short-Term Indebtedness SYRS|TBIO (Telesis Bio) - Company Short-Term Debts|Company Short-Term Indebtedness TCON (TRACON Pharmaceuticals Inc.)|Company Short-Term Debt Unity Bio (UBX)